Clinical trial
Trabectedin for Recurrent Grade II/III Meningioma
The aim of this study is to collect data on activity, toxicity and quality of life of trabectedin therapy in patients with recurrent high-grade meningioma.
| Category | Value |
|---|---|
| Study start date | 2014-08-07 |